CSPC Good Will from 2010 to 2025

300765 Stock   35.16  0.32  0.92%   
CSPC Innovation's Good Will is decreasing over the years with slightly volatile fluctuation. Good Will is expected to dwindle to about 2.8 M. Good Will is an intangible asset that arises when CSPC Innovation Pharmaceutical acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors. View All Fundamentals
 
Good Will  
First Reported
2010-12-31
Previous Quarter
3.1 M
Current Value
2.8 M
Quarterly Volatility
188.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check CSPC Innovation financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CSPC Innovation's main balance sheet or income statement drivers, such as Tax Provision of 82.2 M, Net Interest Income of 78.8 M or Interest Income of 79.6 M, as well as many indicators such as . CSPC financial statements analysis is a perfect complement when working with CSPC Innovation Valuation or Volatility modules.
  
This module can also supplement various CSPC Innovation Technical models . Check out the analysis of CSPC Innovation Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in CSPC Stock

CSPC Innovation financial ratios help investors to determine whether CSPC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CSPC with respect to the benefits of owning CSPC Innovation security.